Biofourmis procures $100m Series C
Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.
3 September 2020•1 min read
Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.